Uncategorized
Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial
Team Metabolic Health A small clinical trial suggests that drugs like Ozempic could potentially be used not just for diabetes…
Eli Lilly Mounjaro Zepbound Novo Nordisk
Lilly’s tirzepatide has shown its worth in another prominent disease as the company races to establish more manufacturing capacity for…
Indian researchers reveal how high-carbohydrate diet could reduce lifespan
A new study from Ashoka University highlights the adverse effects of high-carbohydrate diets, using fruit flies to draw parallels to…
India could soon allow ‘game-changing’ weight-loss drug tirzepatide: How it works, its side effects
Obesity drugs are also not one-time miracle solutions for weight loss. But in recent years, the development of such drugs…
Novo owner backs Swiss biotech Asceneuron in $100 million round
Swiss biotech company Asceneuron said on Tuesday it had raised $100 million from investors including the controlling shareholder of Wegovy…
AI-Skilled Workers Are The New, Hot, In-Demand Professionals
Team Metabolic Health Employers have aggressively sought out technical AI talent, resulting in a 323% increase in hiring. The rapid adoption…
5 everyday healthy hacks for an impressive weight loss
Team Metabolic Health Integrating these 5 everyday healthy hacks into your lifestyle can make a noticeable difference in your weight…
If MPs and MLAs were treated at village health centres that would drive strengthening of these facilities: K Srinath Reddy
K. Srinath Reddy is a public health intellectual who doesn’t mince words. An alumnus of Osmania General Hospital, the honorary…
Lilly says weight loss drug cuts heart failure risk by 38% in trial
Team Metabolic Health Trial results show Eli Lilly’s (LLY.N), opens new tab weight loss drug Zepbound reduces the risk of hospitalization, death…
India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?
FP Explainers Eli Lilly, the pharmaceutical company, has received the first approval for the sale of its blockbuster drug Tirzepatide…